Service provider of high content imaging-based phenotypic assay development and screening services.
Assay areas include:
3D Assay Development for a variety of cell types and models
Human iPS-derived Neuronal Health (Outgrowth, Autophagy, Synapse formation, Mitochondrial function)
Mitochondrial structure and function
Uptake and Subcellular localization of Therapeutic Antibodies
Differentiation of human primary cells
Metabolic function and disorders
Immuno-oncology screens
For more information contact our scientists today at contact@phenovista.com
Follow us on twitter http://twitter.com/phenovista
Assay areas include:
3D Assay Development for a variety of cell types and models
Human iPS-derived Neuronal Health (Outgrowth, Autophagy, Synapse formation, Mitochondrial function)
Mitochondrial structure and function
Uptake and Subcellular localization of Therapeutic Antibodies
Differentiation of human primary cells
Metabolic function and disorders
Immuno-oncology screens
For more information contact our scientists today at contact@phenovista.com
Follow us on twitter http://twitter.com/phenovista
Location: United States, California, San Diego
Employees: 11-50
Phone: +1 858-465-9175
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | BroadOak C... | broadoak.c... |
Mentions in press and media 6
| Date | Title | Description |
| 26.05.2026 | InSphero acquires PhenoVista to expand US presence | Founded in 2009 as a spin-off from ETH Zurich, Schlieren-based InSphero develops 3D in vitro models for drug safety and efficacy testing. Its spheroid-based models—clusters of cells grown in three dimensions to mimic human tissue more clos... |
| 21.05.2026 | InSphero Accelerates Global Growth and US Expansion with Acquisition of PhenoVista Biosciences | Strategic acquisition strengthens InSphero’s US presence and expands advanced imaging and phenotypic analysis capabilities for drug discovery and safety testing This acquisition helps us better serve customers by combining cutting-edge biol... |
| 18.01.2022 | PhenoVista Biosciences Receives Growth Capital From BroadOak Capital Partners | PhenoVista Biosciences, a San Diego, California-based provider of imaging-based, phenotypic assay services, secured funding from BroadOak Capital Partners, a life science-focused investor. The amount of the deal was not disclosed. The inves... |
| 06.01.2022 | FUJIFILM Cellular Dynamics and PhenoVista Biosciences Announce Strategic Alliance to Improve the Drug Discovery Process | MADISON, Wis., and SAN DIEGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem cell (iPSC) technologies, and PhenoVista Biosciences (PhenoVista... |
| 14.07.2021 | Inventia Life Science Announces Partnership with PhenoVista Biosciences to Accelerate Preclinical Research with 3D Cell Models | The vision for RASTRUM is to revolutionise the way we approach the drug discovery process by accelerating the evolution of drugs from the lab bench to the hospital bed - Dr. Julio Ribeiro, CEO of Inventia Life Science SYDNEY (PRWEB) July 14... |
| 28.10.2019 | Yokohama Regional Business Conference provides US-Japan business matching | Yokohama’s Regional Business Conference (RBC) took place from October 8-10 earlier this month. Representatives from 9 North American and German Life Science companies were invited to Yokohama to promote the city’s business environment. Yoko... |